These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27743758)

  • 1. Mutagenic Factors and Complex Clonal Relationship of Multifocal Urothelial Cell Carcinoma.
    Du Y; Li R; Chen Z; Wang X; Xu T; Bai F
    Eur Urol; 2017 May; 71(5):841-843. PubMed ID: 27743758
    [No Abstract]   [Full Text] [Related]  

  • 2. Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.
    Hafner C; Knuechel R; Stoehr R; Hartmann A
    Int J Cancer; 2002 Sep; 101(1):1-6. PubMed ID: 12209580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tract.
    Li M; Cannizzaro LA
    Hum Pathol; 1999 Oct; 30(10):1197-200. PubMed ID: 10534167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.
    Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M
    Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma.
    Harris T; Sheel A; Zong Y; Hutchinson LM; Cornejo KM; Bubendorf L; Yates J; Fischer AH
    J Am Soc Cytopathol; 2021; 10(1):94-102. PubMed ID: 33184010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H; Hara I; Kamidono S; Eto H
    J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the origin of syn- and metachronous urothelial carcinomas.
    Höglund M
    Eur Urol; 2007 May; 51(5):1185-93; discussion 1193. PubMed ID: 17123702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for neoadjuvant checkpoint blockade response in urothelial cancer.
    Ghatalia P; Plimack E
    Nat Med; 2019 Nov; 25(11):1650-1651. PubMed ID: 31686037
    [No Abstract]   [Full Text] [Related]  

  • 9. Glutathione S-transferase expression in upper urinary tract urothelial carcinomas: a Taiwan study.
    Chen SH; Wu WJ; Tu HP; Li WM; Huang CN; Li CC; Lin HH; Ke HL
    Asian Pac J Cancer Prev; 2013; 14(11):6475-9. PubMed ID: 24377553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-Rich Variant of Urothelial Carcinoma Presenting as the Dominant Morphology in a Recurrent Tumor After Local Therapy.
    Patel A; Velilla RE; Shurbaji MS
    Am J Case Rep; 2018 Apr; 19():478-481. PubMed ID: 29681613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract.
    Takahashi T; Habuchi T; Kakehi Y; Mitsumori K; Akao T; Terachi T; Yoshida O
    Cancer Res; 1998 Dec; 58(24):5835-41. PubMed ID: 9865743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
    Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M
    Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of bilateral breast cancer.
    Imyanitov EN; Hanson KP
    Cancer Lett; 2003 Feb; 191(1):1-7. PubMed ID: 12609703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation.
    Kawanishi H; Takahashi T; Ito M; Matsui Y; Watanabe J; Ito N; Kamoto T; Kadowaki T; Tsujimoto G; Imoto I; Inazawa J; Nishiyama H; Ogawa O
    Br J Cancer; 2007 Jul; 97(2):260-6. PubMed ID: 17579624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TP53 mutations in synchronous and metachronous bilateral breast carcinomas.
    Suspitsin EN; Due EU; Vu P; Hirvonen A; Børresen-Dale AL; Imyanitov EN
    Cancer Genet Cytogenet; 2008 Jul; 184(2):119-21. PubMed ID: 18617062
    [No Abstract]   [Full Text] [Related]  

  • 16. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
    Brinkmann D; Ryan A; Ayhan A; McCluggage WG; Feakins R; Santibanez-Koref MF; Mein CA; Gayther SA; Jacobs IJ
    J Natl Cancer Inst; 2004 Oct; 96(19):1441-6. PubMed ID: 15467033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic, staging, and grading of urothelial carcinomas from urine: performance of BCA-1, a mini-array comparative genomic hybridisation-based test.
    Larré S; Camparo P; Comperat E; Gil Diez De Medina S; Traxer O; Roupret M; Sebe P; Cancel-Tassin G; Sighar K; Lozach F; Cussenot O
    Eur Urol; 2011 Feb; 59(2):250-7. PubMed ID: 21056532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foreword: JASC urine cytology special edition.
    Wojcik EM; Pambuccian SE; Rosenthal DL
    J Am Soc Cytopathol; 2021; 10(1):1-2. PubMed ID: 33168474
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
    Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.